Jd. Sandy et al., Versican V1 proteolysis in human aorta in vivo occurs at the Glu(441)-Ala(442) bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4, J BIOL CHEM, 276(16), 2001, pp. 13372-13378
Mature human aorta contains a 70-kDa versican fragment, which reacts with a
neoepitope antiserum to the C-terminal peptide sequence DPEAAE. This prote
in therefore appears to represent the G1 domain of versican V1 (G1-DPEAAE(4
41)), which has been generated in vivo by proteolytic cleavage at the Glu(4
41)-Ala(442) bond, within the sequence DPEAAE(441)-A(442)RRGQ. Because the
equivalent aggrecan product (G1-NITEGE(341)) and brevican product (GI-EAVES
E(395)) are generated by ADAMTS-mediated cleavage of the respective proteog
lycans, we tested the capacity of recombinant ADAMTS-1 and ADAMTS-4 to clea
ve versican at Glu(441)-Ala(442). Both enzymes cleaved a recombinant versic
an substrate and native human versican at the Glu(441)-Ala(442) bond and th
e mature form of ADAMTS-4 was detected by Western analysis of extracts of a
ortic intima. We conclude that versican V1 proteolysis in vivo can be catal
yzed by one or more members of the ADAMTS family of metalloproteinases.